XETRE8X
Market cap2mUSD
Dec 23, Last price
0.25EUR
1D
-2.36%
1Q
-32.97%
Jan 2017
22.77%
IPO
-93.49%
Name
Elexxion AG
Chart & Performance
P/E
—
P/S
—
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
-14.25%
Revenues
0k
-100.00%
Net income
0k
P
CFO
0k
-100.00%
Profile
elexxion AG develops, produces, and sells dental lasers for soft and hard tissue applications primarily in Germany. The company offers dental diode lasers under the elexxion pico, elexxion nano, and elexxion claros names; and elexxion pico lite, a soft laser therapy. It also provides Odobleach; SNORE3 therapy; and perio green, a therapy product for the photothermal therapy of periodontology and periimplantitis, as well as repair services. The company was founded in 2002 and is headquartered in Singen, Germany. elexxion AG is a subsidiary of Tian Ying Medical Instrument Co., Ltd.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
| Income | |||||||||
Revenues | 1,029 40.46% | ||||||||
Cost of revenue | 23 | 1,059 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (23) | (30) | |||||||
NOPBT Margin | |||||||||
Operating Taxes | 390 | ||||||||
Tax Rate | |||||||||
NOPAT | (23) | (30) | |||||||
Net income | (358) -47.83% | ||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | 3,460 | ||||||||
Long-term debt | 3,460 | ||||||||
Deferred revenue | |||||||||
Other long-term liabilities | (3,310) | ||||||||
Net debt | 6,844 | ||||||||
| Cash flow | |||||||||
Cash from operating activities | 16 | ||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | 593 | (56) | |||||||
| Balance | |||||||||
Cash | 77 | ||||||||
Long term investments | 1 | ||||||||
Excess cash | 25 | ||||||||
Stockholders' equity | (9,259) | ||||||||
Invested Capital | 4,545 | 9,930 | |||||||
ROIC | |||||||||
ROCE | 0.10% | ||||||||
| EV | |||||||||
Common stock shares outstanding | 9,896 | 9,896 | |||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | (23) | (30) | |||||||
EV/EBITDA | |||||||||
Interest | 116 | 109 | |||||||
Interest/NOPBT | |||||||||